A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, AND CONTROLLED STUDY OF TREATMENT WITH HYDROCORTISONE-ETHANOL GEL OINTMENT IN CHILDREN’S WITH MODERATE-TOSEVERE ATOPIC DERMATITIS

Authors

  • ARTI BHABHOR Department of Dermatology, Parul Institute of Medical Sciences and Research, Parul University, Vadodara, Gujarat, India.
  • RUTU HARSH OZA Consultant Dermatologist, Ahmedabad, Gujarat, India.
  • PRATIK MAKWANA Department of Dermatology, Dr. N. D. Desai Faculty of Medical Sciences and Research, Dharmsinh Desai University, Nadiad, Gujarat, India.
  • Krunal Tralsawala Department of Dermatology, Parul Institute of Medical Sciences and Research, Parul University, Vadodara, Gujarat, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i7.47497

Keywords:

Atopic dermatitis (AD), pruritus, Hydrocortisone

Abstract

Objectives: The objective is to see the effectiveness of hydrocortisone (HC)-ethanol gel (EG) ointment in treating children with Moderate-to-severe atopic dermatitis (AD).

Methods: Thirty children with moderate-to-severe AD participated in a 2-week double-blind, randomized, and controlled clinical trial. They were randomly assigned to apply either an ointment with 1% HC ointment or a novel ointment containing 1% HC and dispersed EG droplets HC. At the end of 2 week, SCORAD score was measured. SCORAD is a clinical tool used to assess the extent and severity of eczema (SCORing AD).

Results: A 2-week double-blind, randomized, and controlled clinical trial included 30 kids with moderate-to-severe AD. About 1% HC ointment or a new ointment comprising 1% HC and dispersed EG droplets were applied to them at random (HC-EG). The SCORAD score was calculated at the conclusion of 2 weeks. A clinical tool called SCORAD is used to evaluate the severity and extent of eczema (SCORing AD).

Conclusion: We would want to draw the conclusion from our research that HC-EG ointment was superior to HC ointment in terms of reducing AD-related pruritus and visible rash.

Downloads

Download data is not yet available.

References

Spuls PI, Gerbens LA, Simpson E, Apfelbacher CJ, Chalmers JR, Thomas KS, et al. Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: A Harmonising Outcome Measures for Eczema (HOME) statement. Br J Dermatol 2017;176:979-84. doi: 10.1111/bjd.15179, PMID 27858989

Ersser SJ, Cowdell F, Latter S, Gardiner E, Flohr C, Thompson AR, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev 2014;2014:CD004054. doi: 10.1002/14651858.CD004054.pub3, PMID 24399641

National Institute for Health and Care Excellence. Atopic Eczema in Children: Management of Atopic Eczema in Children from Birth up to the Age of 12 Years. Available from: http://www.nice.org.uk/nicemedia/ pdf/Cg057fullguideline.pdf [Last accessed on 2009 Mar 15].

Langan SM, Bourke JF, Silcocks P, Williams HC. An exploratory prospective observational study of environmental factors exacerbating atopic eczema in children. Br J Dermatol 2006;154:979-80. doi: 10.1111/j.1365-2133.2006.07153.x, PMID 16634905

Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): Clinical update and current treatment strategies. Br J Dermatol 2003;148(Suppl 63):3-10. doi: 10.1046/j.1365-2133.148. s63.1.x, PMID 12694268

Darsow U, Laifaoui J, Kerschenlohr K, Wollenberg A, Przybilla B, Wüthrich B, et al. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: A European multicenter study. Allergy 2004;59:1318-25. doi: 10.1111/j.1398-9995.2004.00556.x, PMID 15507101

Cho SH, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrinogen contributes to the enhanced binding of S. aureus to atopic skin. J Allergy Clin Immunol 2001;108:269-74. doi: 10.1067/ mai.2001.117455, PMID 11496245

Zollner TM, Wichelhaus TA, Hartung A, Von Mallinckrodt C, Wagner TO, Brade V, et al. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000;30:994-1000. doi: 10.1046/j.1365- 2222.2000.00848.x, PMID 10848922

Santer M, Ridd MJ, Francis NA, Stuart B, Rumsby K, Chorozoglou M, et al. Emollient bath additives for the treatment of childhood eczema (BATHE): Multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness. BMJ 2018;361:k1332. doi: 10.1136/bmj.k1332, PMID 29724749

Santer M, Rumsby K, Ridd MJ, Francis NA, Stuart B, Chorozoglou M, et al. Adding emollient bath additives to standard eczema management for children with eczema: The BATHE RCT. Health Technol Assess 2018;22:1-116. doi: 10.3310/hta22570, PMID 30362939

Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: Responsiveness and minimal clinically important difference. Allergy 2012;67:99-106. doi: 10.1111/j.1398-9995.2011.02719.x, PMID 21951293

Gaunt DM, Metcalfe C, Ridd M. The Patient-Oriented Eczema Measure in young children: Responsiveness and minimal clinically important difference. Allergy 2016;71:1620-5. doi: 10.1111/all.12942, PMID 27232584

Levin J, Friedlander SF, Del Rosso JQ. Atopic dermatitis and the stratum corneum: Part 1: The role of filaggrin in the stratum corneum barrier and atopic skin. J Clin Aesthet Dermatol 2013;6:16-22. PMID 24155988

Cerrato S, Ramió-Lluch L, Brazís P, Fondevila D, Segarra S, Puigdemont A. Effects of sphingolipid extracts on the morphological structure and lipid profile in an in vitro model of canine skin. Vet J 2016;212:58-64. doi: 10.1016/j.tvjl.2016.03.020, PMID 27256026

Koppes SA, Charles F, Lammers L, Frings-Dresen M, Kezic S, Rustemeyer T. Efficacy of a cream containing ceramides and magnesium in the treatment of mild to moderate atopic dermatitis: A randomized, double-blind, emollient-and hydrocortisone-controlled trial. Acta Derm Venereol 2016;96:948-53. doi: 10.2340/00015555- 2395, PMID 26939522

Published

07-07-2023

How to Cite

BHABHOR, A., R. HARSH OZA, P. MAKWANA, and K. Tralsawala. “A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, AND CONTROLLED STUDY OF TREATMENT WITH HYDROCORTISONE-ETHANOL GEL OINTMENT IN CHILDREN’S WITH MODERATE-TOSEVERE ATOPIC DERMATITIS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 7, July 2023, pp. 154-6, doi:10.22159/ajpcr.2023.v16i7.47497.

Issue

Section

Original Article(s)